![Kamel Besseghir](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kamel Besseghir
Direttore/Membro del Consiglio presso
ONCODESIGN
Profilo
Kamel Besseghir is currently an Independent Director at Oncodesign SA since 2014 and a Director at Oncodesign Precision Medicine SA since 2022.
Formerly, Dr. Besseghir was Chief Executive Officer at Debiopharm International SA from 1995 to 2012.
Other former roles include Principal positions at Serono SA, The State University of New York, and the University of Lausanne.
Posizioni attive di Kamel Besseghir
| Società | Posizione | Inizio |
|---|---|---|
| ONCODESIGN | Direttore/Membro del Consiglio | 03/02/2014 |
| ONCODESIGN PRECISION MEDICINE | Direttore/Membro del Consiglio | 14/09/2022 |
Precedenti posizioni note di Kamel Besseghir
| Società | Posizione | Fine |
|---|---|---|
Debiopharm International SA
 Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Presidente | 01/01/2012 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Corporate Officer/Principal | - |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Oncodesign Precision Medicine SA
 Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
